Polly A. Niravath, MD

Assistant Professor of Clinical Medicine in Oncology, Academic Institute
Department of Medicine
Cancer Center
Houston Methodist
Weill Cornell Medical College

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Area Keywords

Cancer
Clinical Care
Clinical Translation & Trials

Fingerprint

Dive into the research topics where Polly A. Niravath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished
8 Not started
57 Active

Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843 A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Niravath, P. A., Chang, J. C., Darcourt, J. & Geyer, C. E.
4/28/21 → …
Project: Clinical Trial
Phase II_IL-12 and L-NMMA_Triple Negative Breast Cancer_Merck INTEGRAL study
Darcourt, J., Geyer, C. E., Niravath, P. A. & Venta, L. A.
3/12/21 → …
Project: Clinical Trial
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B., Chen, S., Niravath, P. A., Rosato, R. R. & Xu, S.
3/1/21 → 2/29/24
Project: Federal Funding Agencies
Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Chang, J. C., Darcourt, J., Geyer, C. E. & Niravath, P. A.
2/9/21 → …
Project: Clinical Trial
MOCHA 1.2 Study
Stubbins, R. E., Darcourt, J., Niravath, P. A., Satkunasivam, R. & Wong, S. T.
1/25/21 → …
Project: Clinical Trial

716 Citations
9 h-Index
29 Article
7 Review article
2 Letter
1 Chapter

ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Koca, E., Niravath, P. A., Ensor, J., Patel, T., Li, X., Hemati, P., Wong, H., Qian, W., Boone, T., Zhao, J., Ramshesh, P. V., Cohen, A. L., Murthy, A., Nair, S., Darcourt, J., Belcheva, A., Kaklamani, V. G. & Chang, J. C., 2021, (Accepted/In press) In : Breast Cancer Research and Treatment.
Research output: Contribution to journal › Article
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy
Anand, K., Patel, T., Niravath, P., Rodriguez, A., Darcourt, J., Belcheva, A., Boone, T., Ensor, J. & Chang, J., Dec 2021, In : Scientific Reports. 11, 1, 82.
Research output: Contribution to journal › Article

Open Access
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer
Anand, K., Niravath, P., Patel, T., Ensor, J., Rodriguez, A., Boone, T., Wong, S. T. & Chang, J. C., 2020, (Accepted/In press) In : Clinical Breast Cancer.
Research output: Contribution to journal › Article
1 Scopus citations
Comparison of outcomes between metaplastic and triple-negative breast cancer patients
Polamraju, P., Haque, W., Cao, K., Verma, V., Schwartz, M., Klimberg, V. S., Hatch, S., Niravath, P., Butler, E. B. & Teh, B. S., Feb 2020, In : Breast. 49, p. 8-16 9 p.
Research output: Contribution to journal › Article
3 Scopus citations
TBCRC023: A randomized phase II neoadjuvant trial of lapatinib plus trastuzumab without chemotherapy for 12 versus 24 weeks in patients with HER2-positive breast cancer
on behalf of the Translational Breast Cancer Research Consortium, Feb 15 2020, In : Clinical Cancer Research. 26, 4, p. 821-827 7 p.
Research output: Contribution to journal › Article
6 Scopus citations